HR
SRNE

Howe & Rusling’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Howe & Rusling’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,000
Closed -$3K – 1126
2022
Q3 		$3K Sell
2,000
-200
-9% -$454 ﹤0.01% 830
2022
Q2 		$4K Buy
2,200
+200
+10% +$346 ﹤0.01% 746
2022
Q1 		$5K Buy
2,000
+1,000
+100% +$3.12K ﹤0.01% 683
2021
Q4 		$5K Hold
1,000
– – ﹤0.01% 699
2021
Q3 		$8K Hold
1,000
– – ﹤0.01% 556
2021
Q2 		$10K Hold
1,000
– – ﹤0.01% 503
2021
Q1 		$8K Hold
1,000
– – ﹤0.01% 537
2020
Q4 		$7K Hold
1,000
– – ﹤0.01% 556
2020
Q3 		$11K Buy
+1,000
New +$9.15K ﹤0.01% 434

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM